Programa de Pós-Graduação Interunidades em Biotecnologia Universidade de São Paulo (ICB, IB, FMVZ, EP) - Instituto Butantan - Instituto de Pesquisas Tecnológicas
Facebook

Advisors

Advisors of the Graduate Program in Biotechnology (PPIB)

Universidade de São Paulo/Instituto Butantan/Instituto de Pesquisa Tecnológica

(Lattes is a curriculum vitae of the Brazilian government)

FULL Advisors (which can accept new students without re-accreditation)
(For the period of accreditation, please access USP Janus System with “Código da Área:” 87131)

Name – Institution Research focus Email (@) Lattes (#)
Aldo Tonso
Escola Politécnica/USP
Bioprocess Engineering, with emphasis on: bioproducts production with animal cells, production of asparaginase, andmonitoring and control of cultures in bioreactors (sites.usp.br/genbio) @ #
Ana Clara Guerrini Schenberg
Instituto de Ciências Biomédicas/USP
Biotechnological approaches for Sustainable Development @ #
Ana Lucia Tabet Oller do Nascimento
Instituto Butantan
Functional Genomics of Leptospira interrogans: pathogenesis, vaccine and diagnostic @ #
Ana Maria Moro
Instituto Butantan
Development of monoclonal antibodies, antibodies’ humanization, neutralizing human antibodies, antibodies’ engineering, cell line development, cell cultivation processes @ #
Ana Marisa Chudzinski Tavassi
Instituto Butantan
#
Ana Olívia de Souza
Instituto Butantan
Use of microorganisms in obtainment of bioactive molecules and biosynthesis of metallic nanoparticles for the development of products and/or nanomaterials for pharmaceutical or biotechnological use @ #
Andrea Balan Fernandes
Instituto de Ciências Biomédicas/USP
Our group’s main objective is the study of membrane and associated proteins involved in the import and export of different molecules in all organisms @ #
Anita Mitico Tanaka Azevedo
Instituto Butantan
Biochemistry of snake plasmas and venoms and isolated proteins, focusing in factor that influence venom variability, such as seasonal variation, captivity, age and sex, as well as on antivenoms and phospholipases A2 inhibitors @ #
Carlos Frederico Martins Menck
Instituto de Ciências Biomédicas/USP
This work aims to understand the molecular mechanisms that ensure genomic stability in cells, and the consequences of unrepaired DNA damage, such as carcinogenesis and aging @ #
Douglas Galante
Centro Nacional de Pesquisa em Energia e Materiais/Campinas
#
Eliana Nakano
Instituto Butantan
– Development of anthelminthic drugs from natural sources using new approaches (metabolomic analysis)
– Environmental studies: toxicity and mutagenicity analysis (molluscs as bioindicators)
@ #
Eliane Namie Miyaji
Instituto Butantan
Evaluation of protein antigens in the development of vaccines against Streptococcus pneumoniae, focusing on the study of cross-reactivity with different isolates and use of nanoparticles @ #
Eny Iochevet Segal Floh
Instituto de Biociências/USP
#
Felipe Santiago Chambergo Alcalde
Escola de Artes, Ciências e Humanidades/USP
Expert in molecular biology, metagenomics and biotechnological processes @ #
Fernanda Calheta Vieira Portaro
Instituto Butantan
Purification and characterization of biomolecules present in venoms and secretions from animals for pharmaceutical or biotechnological use. Enzymatic analyses of substrates and inhibitors @ #
Gabriel Padilla Maldonado
Instituto de Ciências Biomédicas/USP
#
Igor Cesarino
Instituto de Biociências/USP
Unraveling molecular mechanisms underlying different aspects of lignin metabolism. Lignin bioengineering is envisaged to generate optimized crops with enhanced biomass extractability for biorefineries @ #
João Tadeu Ribeiro Paes
Universidade Estadual Paulista/Assis
#
José Antonio Visintin
Faculdade de Medicina Veterinária e Zootecnia/USP
#
José Gregório Cabrera Gomez
Instituto de Ciências Biomédicas/USP
Metabolic Engineering applied to bioprocesses to replace petrochemical products (Biorefineries). Bacterial metabolism (Bioproducts synthesis and consumption of low-cost raw materials) @ #
José Ribamar dos Santos Ferreira Júnior
Escola de Artes, Ciências e Humanidades/USP
We express human genes in yeast (humanized yeast) to screen for natural products that inhibit proteins involved in diseases related to aging (heart disease, neurodegenerative, and neoplasic) @ #
Kelly Ishida
Instituto de Ciências Biomédicas/USP
To develop new antifungals by the following strategies: natural products,synthetic molecules, drug repurposing, incorporation of antifungal agents in carrier systems, using in vitro andin vivo models @ #
Luciana Cezar de Cerqueira Leite
Instituto Butantan
#
Lucio Holanda Gondim de Freitas Júnior
Instituto de Ciências Biomédicas/USP
#
Luis Carlos de Souza Ferreira
Instituto de Ciências Biomédicas/USP
Vaccine Development Laboratory (LDV): vaccines based on purified recombinant proteins, DNA and mRNA vaccines (genetic vaccines) as well as vectorized vaccines @ #
Luiziana Ferreira da Silva
Instituto de Ciências Biomédicas/USP
#
Lygia da Veiga Pereira Carramaschi
Instituto de Biociências/USP
#
Marcelo Palma Sircili
Instituto Butantan
Bacteria and host- bacteria interactions mediated by chemical signaling, and quorum sensing. Bacterial pathogenicity, gene regulation, and biofilm formation mediated by signaling molecules @ #
Marcos Silveira Buckeridge
Instituto de Biociências/USP
#
Margareth de Lara Capurro Guimaraes
Instituto de Ciências Biomédicas/USP
#
Mari Cleide Sogayar
Faculdade de Medicina/USP
#
Marie Anne van Sluys
Instituto de Biociências/USP
#
Natália Neto Pereira Cerize
Instituto de Pesquisas Tecnológicas/IPT
#
Oswaldo Keith Okamoto
Instituto de Biociências/USP
Research, development and innovation, focusing on stem cell biology and cancer, translationalgenomics and development of advanced therapies applied to human health @ #
Pedro Ismael da Silva Junior
Instituto Butantan
Study of bioactive molecules of toxins of invertebrates and hemolymph (purification, characterization and synthesis), acting on the following topics: antimicrobial, antiviral and antitumor @ #
Renato Mancini Astray
Instituto Butantan
Development of viral vaccines using isolates, attenuated viruses or recombinant expression. Studies on technologies and processes for the production and purification of viruses for pharmaceutical use @ #
Rosane Aparecida Moniz Piccoli
Instituto de Pesquisas Tecnológicas/IPT
Bioprocess Optimization in bioreactors: in the production of recombinant proteins, bio products and vaccines; in the modeling, simulation and mathematical bioprocess optimization; in economic feasibility studies for biotechnological processes. @ #
Soraia Attie Calil Jorge
Instituto Butantan
#
Viviane Maimoni Gonçalves
Instituto Butantan
Bioprocess development for production of new vaccines, including microbial cell culture to reach high cell density in bioreactor and scalable processes for purification of the antigens @ #

 

PONTUAL Advisers (who need to require accreditation for each new student)

 

Name – Institution Research focus Email (@) Lattes (#)
Adriana Rios Lopes Rocha
Instituto Butantan
Molecular physiology in Arachnida: digestion, envenoming and enzymatic catalysis. Characterization of proteins and enzymes involved in digestion (spiders, scorpions, ticks and mites) @ #
Alexandre Paulo Yague Lopes
Instituto Butantan
Main projects are “Studies on bacterial toxin-antitoxin systems of Leptospira interrogans“, in addition to the “Expression of recombinant proteins of biotechnological importance in E. coli @ #
Alfredo Eduardo Maiorano
Instituto de Pesquisas Tecnológicas – IPT
Our research work is focused on the development of bioprocesses for obtaining bioproducts of societal value @ #
Andreas Karoly Gombert
Faculdade de Engenharia de Alimentos – Unicamp
Yeasts: physiology, metabolic engineering, industrial biotechnology, ecology and evolution @ #
Antônio José Piantino Ferreira
Faculdade de Medicina Veterinária e Zootecnia – USP
#
Beatriz Nogueira Messias de Miranda
Instituto de Pesquisas Tecnológicas – IPT
#
Beny Spira
Instituto de Ciências Biomédicas – USP
#
Carlos Roberto Prudencio
Centro de Imunologia, Instituto Adolfo Lutz
Phage display of synthetic peptidome libraries for quantitative and comprehensive antibody profiling analysis, in addition to recombinant monoclonal antibody libraries as prospecting methods in Translational Science and Biopharmaceutical Development @ #
Carlos Roberto Jorge Soares
Instituto de Pesquisas Energéticas e Nucleares
#
Denise Vilarinho Tambourgi
Instituto Butantan
To isolate and characterize components of animal venoms and their respective modes of action, to establish the basis for the development of more efficient therapeutic strategies for the envenomations @ #
Elen Aquino Perpetuo
Universidade Federal de São Paulo – Santos
Experience in the areas of Applied Microbiology and Bioprocesses, working mainly in the development of biotechnological processes for bioremediation, obtaining bioproducts and producing biofuels @ #
Elizabeth Natal de Gaspari
Instituto Adolfo Lutz
New antigenic preparations for different pathogens of public health interest. Evaluation of new adjuvants focusing on humoral, cellular, mucosal and monoclonal with the aim of technological transfer @ #
Fabio Luiz Teixeira Goncalves
Instituto de Astronomia, Geofísica e Ciências Atmosféricas – USP
#
Fabio Rodrigues
Instituto de Química – USP
#
Giovana Cappio Barazzone
Instituto Butantan
Development of conjugate vaccines. Chemical modification of molecules with biotechnological applications.Purification of recombinant proteins @ #
Gustavo Cabral de Miranda
Instituto de Ciências Biomédicas – USP
#
Júlia Pinheiro Chagas da Cunha
Instituto Butantan
#
Karen de Morais Zani
Instituto Butantan
Compositional and functional characterization of snake venoms; Isolation and characterization of biomolecules; Natural inhibitors of snake plasma @ #
Katiucia Batista da Silva Paiva
Instituto de Ciências Biomédicas – USP
Bone bioengineering, biomaterials and biological mineralization; Odontogenic tumors and oral cancer @ #
Leo Kei Iwai
Instituto Butantan
Focused on the study of snakes and scorpion potential anti-tumorigenic effects and the experimental mass spectrometry-based proteomics study of snake envenomation @ #
Lilian Rumi Tsuruta
Instituto Butantan
Monoclonal antibodies using phage display technology, expertise in the construction of naïve or immune library of antibody genes, antibody humanization and expression of recombinant protein in bacteria @ #
Maria Filomena de Andrade Rodrigues
Instituto de Pesquisas Tecnológicas – IPT
#
Maria José de Jesus Silva
Instituto Butantan
Biodiversity: genetics and conservation @ #
Maria Leonor Sarno de Oliveira
Instituto Butantan
Development of vaccines against Streptococcus pneumoniae (pneumococcus). Study of combinations of protein antigens with adjuvants, antigen presentation systems and inoculation routes @ #
Maria Lucia Zaidan Dagli
Faculdade de Medicina Veterinária e Zootecnia/USP
#
Monamaris Marques Borges
Instituto Butantan
Immunology and microbiology associated with host-pathogen interaction. Investigation of compounds. Regulation of macrophage activity in bacterial infections. Immunology in Infections @ #
Murilo Sena Amaral
Instituto Butantan
Screening of new compounds and drugs with antiparasitic activities; Development and testing of vaccines against schistosomiasis using non-human primate models @ #
Paolo Marinho de Andrade Zanotto
Instituto de Ciências Biomédicas – USP
#
Patricia Léo
Instituto de Pesquisas Tecnológicas – IPT
Biotechnological processes with mammalian cell culture. Evaluation of the antitumor, antiviral and antimicrobial safety and efficacy of nanostructured material and different bioactives @ #
Patrícia Severino
Instituto Israelita de Ensino e Pesquisa Albert Einstein
Genomics, gene expression regulation and molecular epidemiology, aiming at the integration of clinical and molecular markers and genome diversity (cancer progression and infections) @ #
Renata Castiglioni Pascon
Universidade Federal de São Paulo – Diadema
#
Rita de Cassia Cafe Ferreira
Instituto de Ciências Biomédicas – USP
#
Viviane Abreu Nunes Cerqueira Dantas
Escola de Artes, Ciências e Humanidades – USP
Expertise in stem cell biology, skin physiology and tissue bioengineering, in addition to studying the molecular mechanism of chronic non-communicable diseases such as gestational diabetes @ #

 

NEW Advisors

If you are interested in being an advisor for the program, please see “Normas”available in the Program / Normas menu, in particular item X (Advisors and co-advisors), of the Regulation of the new Biotechnology Program.